Brain Cancer

"There are many young scientists in a similar position that could greatly benefit from the support at the early stages in their career."


Justin Lathia, PH.D.
Cleveland Clinic

Molecular Studies

"The Ohio Cancer Research award was instrumental in getting my laboratory off the ground as a new faculty member."


Denis Guttridge, PH.D.
The Ohio State University

Breast Cancer

"For many in my position such achevements would not be possible without these early investments and I thank you for supporting OCR and enabling the cutting edge scientific projects of Ohio's talented young researchers."

Matthew Summers, PH.D.
Cleveland Clinic,
The Ohio State University

Gene Mutation

"The Ohio Cancer Research grant really sowed the seed of success for me to acquire $1.8 million federal funding since I joined the University of Toledo."


Song-Tao Liu, PH.D.
University of Toledo

Lung Cancer

"Research matters because lung cancer is poorly understood and current therapies are insufficient to save the lives of patients."

Anne Strohecker, PH.D.
The Ohio State University

Funded with the support of Celeste and David Loewendick

Breast Cancer

"The lifetime risk of developing invasive breast cancer is 1 in 8 in women in the United States and 20% of the breast cancer patients die. We are exploring strategies to reduce breast cancer deaths in the clinic."


Huiping Liu, M.D., PH.D.
Case Western Reserve University

Cancer Therapy

"Metastasis, the spread of cancer from the original tumor to other sites in the body, is the main cause of death in most cancer patients. We believe our research will contribute to the identification of new therapeutic targets to reduce cancer cell invasion and metastasis."


Jennifer Leight, PH.D.
The Ohio State University

Cleveland


Cleveland Clinic

Funded

Generated

MATTHEW K SUMMERS, PHD

The role of p31comet in breast cancer progression and therapy

[Breast Cancer]

2012

$60,000

$770,000

JUSTIN D LATHIA, PHD

Targeting CXCR7 mediated vascular interactions in Glioblastoma

[Breast Cancer]

2012

$60,000

$7,130,494

TAO LU, PHD

Study the role of FBXL 11 protein in colitis associated cancer (CAC).

[Colon cancer]

2010

$60,000

LAN ZHOU, MD, PHD

The Role of Aberrant Notch Signaling in the Chronic Myeloproliferative Disorder Induced by Fucosylation Deficiency

[Leukemia]

2007

$50,000

$636,795

MALACHI MIXON III

Restricted gift (grant) for cancer research

[Special Gift]

2007

$10,000

PATRICK C MA MD

High-Throughput Cell-Based MET Inhibitor Development For Lung Cancer Individualized Therapy

[Lung Cancer]

2006

$50,000

$1,342,660

MARIE-ODILE PARAT, PHAR, MD, PHD

Role of Caveolin-1 in H-Ras Targeting

[Molecular Genetics]

2005

$50,000

$750,000

MARINA ANTOCH, PHD

Diagnostic Markers Of Mammalian Circadian Clock Function

[Cancer Therapy]

2002

$50,000

$1,676,250

NYWANA SIZEMORE, PHD

Molecular Targets Of The PI3K/AKT/IKK Pathway In Breast Cancer

[Breast Cancer]

2002

$49,500

$1,004,824

MICHAEL A VOGELBAUM, MD, PHD

Regulation of Apoptosis in Glioma Primary Cell Cultures

[Brain Cancer]

2001

$50,000

MUNNA AGARWAL, PHD

Identification of molecular components involved in regulation of p53 function

[Gene Mutation]

1999

$50,000

CHRISTINE CAMPBELL, PHD

Role of the T-box genes, TBX2 and TBX3, in breast carcinoma

[Breast Cancer]

1997

$40,000

SIPRA BANERJEE, PHD

Genomic Instability in Familial Breast Cancer

[Breast Cancer]

1995

$40,000

$306,675

TOTAL:

$619,500

$13,617,698

Case Western Reserve University

Funded

Generated

VINAY VARADAN, PhD

lmmunosuppressive mechanisms and response prediction in HER2+ early breast cancer

[Breast Cancer]

2016

$60,000

HUIPING LIU, MD, PHD

Targeting IL-11 in breast tumor initating cell-mediated metastasis

[Breast Cancer]

2015

$60,000

EFSTATHIOS KARATHANASIS, PHD

Treatment of cancer metastasis using a multicomponent nanoparticle

[Chemotherapy Treatment]

2013

$60,000

$2,820,000

NICOLE FRANZISKA STEINMETZ, PHD

A Novel Plant Viral Nanoparticle Drug Delivery System for Treatment of Aggressive HER2+ Breast Cancer

[Breast Cancer]

2012

$60,000

$1,040,000

BARBARA BEDOGNI, PHD

Dissecting the role of the Notch signaling pathway in melanoma metastasis

[Skin Cancer]

2010

$60,000

$1,566,276

DAVID WALD, MD, PHD

Characterization of a novel pathway to selectively target AML cells

[Leukemia]

2010

$60,000

$1,994,201

SCOTT M WELFORD, PHD

The impact of tissue hypoxia on tumor initiation

[Radiation Oncology/Renal Cancer]

2010

$60,000

HORST VON RECUM, PHD

Multiplexing Molecular Interactions to Improve Chemotherapeutic Delivery

[Chemotherapy]

2008

$50,000

$517,450

YANWU YANG, PHD

Structural Mechanism of How SnoN-FHL2 Complex Activates Wnt/beta-catenin Signaling

[Tumor Research]

2007

$50,000

ZHILIN HU, PHD

Bronchoscopic OCT imaging to identify premalignant changes in the pulmonary epithelium

[Lung Cancer]

2006

$49,996

MATTHIAS BUCK, Phd

cMet/Eph Phosphorylation of Small GTPases and their Role in Cancer

[Molecular Genetics]

2006

$49,981

$100,000

HUA LOU, PHD

Medullary Thyroid Carcinoma As A Model To Study Alternative RNA Splicing

[Thyroid Cancer]

2002

$41,830

$3,747,896

NARENDRA NARAYANA, PHD

Crystal Structure Determination of DSX-DNA Complex

[Leukemia]

2002

$25,000

HUNG-YING KAO, PHD

The Role Of GPS2 In Transcriptional Co-Repressor SMRT-Mediated Repression

[Leukemia]

2002

$50,000

$1,729,846

ZHONGWU GUO, PHD

Glycoengineering Cancer Cells for Selective Immunotargeting of Cancer

[Molecular Genetics]

2001

$50,000

$2,859,484

NIHAL AHMAD, PHD

Role of Ornithine Decarboxylase in Phtotcarcinogenesis

[Skin and Prostate Cancer]

2001

$25,000

NIHAL AHMAD, PHD

Resveratrol in Prevention of Cancer

[Skin and Prostate Cancer]

1999

$50,000

$2,903,763

SANTOSH KATIYAR, PHD

UV-induced oxidative stress-mediated human skin cancer, and prevention by antioxidants

[Skin Cancer]

1999

$50,000

$2,462,935

DAVID DANIELPOUR, PHD

Regulation of TGF-beta signal transduction by IGF-in prostatic cells

[Prostate Cancer]

1999

$50,000

$4,274,659

MONICA MONTANO, PHD

Estrogen Receptor-Selective Coactivators in Breast Cancer Cells

[Breast Cancer]

1999

$50,000

$3,130,875

ANTONIO GUALBERTO, MD

Altered Mitotic Checkpoint in p53 mutant cells

[Gene Mutation]

1999

$9,662

RAJESH AGARWAL, PHD

Antioxidants and Prostate Cancer Chemoprevention

[Prostate Cancer]

1997

$40,000

$5,769,264

ELLEN RORKE, PHD

Epidermal Growth Factor in Human Cervical Cancer

[Cervical Cancer]

1995

$40,000

PHILIP PAUL GARNER, PHD

The Development of Novel Oligonucleotide Surrogates

[Gene Mutation]

1994

$40,000

$309,500

SANFORD MARKOWITZ, MD, PHD

Novel Markers of Colon Cancer Progression and Prognosis

[Colon Cancer]

1994

$40,000

$6,040,281

CLARK W DISTELHORST, MD

Steroid Receptor Nuclear Uptake Mechanism

[Hormone Therapy]

1993

$39,753

$7,980,830

TOTAL:

$1,221,222

$49,247,260

Metrohealth Medical Center

Funded

Generated

ARUNA BASU, PHD

Functional Analysis of LKB1 Gene Linked to Peutz-Jeghers Syndrome

[Pancreatic Cancer]

2010

$49,848

$251,000

SUBRATA HALDAR, PHD

Epigenetic Inactivation of Apaf-1 in Metastatic Melanoma

[Skin Cancer]

2002

$49,996

BRUCE AVERBOOK, MD FASC

Brain Tumor Immunosuppression of Tumor Draining Lymph Node Antitumor

[Brain Cancer]

1997

$40,000

TOTAL:

$139,844

$251,000